Tryptamine Therapeutics Limited

CHIA:TYP Stock Report

Market Cap: AU$32.2m

Tryptamine Therapeutics Management

Management criteria checks 1/4

Tryptamine Therapeutics' CEO is Jason Carroll, appointed in Oct 2023, has a tenure of less than a year. directly owns 2.51% of the company’s shares, worth A$808.50K. The average tenure of the management team and the board of directors is 1.6 years and 3.4 years respectively.

Key information

Jason Carroll

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership2.5%
Management average tenure1.6yrs
Board average tenure3.4yrs

Recent management updates

Recent updates


CEO

Jason Carroll

less than a year

Tenure

Mr. Jason Carroll serves as Chief Executive Officer of Tryp Therapeutics Inc. since October 01, 2023 and serves as its Managing Director since 2024 and serves as its Executive Director. He has a wealth of...


Leadership Team

NamePositionTenureCompensationOwnership
James Gilligan
President & Chief Scientific Officer3.7yrsCA$390.05kno data
James O'Neill
Chief Financial Officer1.8yrsCA$121.26kno data
Peter Molloy
Chief Business Officer & Executive Directorless than a yearCA$183.59k0.049%
CA$ 15.9k
Jason Carroll
MD, CEO & Executive Directorless than a yearno data2.51%
CA$ 808.5k
William Garner
Founder & MDno dataCA$56.43k4.1%
CA$ 1.3m
Michael Silverman
Chief Medical Officer1.6yrsno datano data
David Franks
Company Secretaryno datano datano data

1.6yrs

Average Tenure

61yo

Average Age

Experienced Management: TYP's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Peter Molloy
Chief Business Officer & Executive Directorno dataCA$183.59k0.049%
CA$ 15.9k
Jason Carroll
MD, CEO & Executive Directorno datano data2.51%
CA$ 808.5k
William Schmidt
Member of Scientific Advisory Board3.5yrsno datano data
P. Jull
Independent Non-Executive Director3.8yrsCA$26.67k0.11%
CA$ 36.9k
Christopher Ntoumenopoulos
Independent Non Executive Director2.2yrsno data0.43%
CA$ 137.5k
Mark Davies
Independent Non-Executive Chairmanno datano data0.14%
CA$ 44.0k
Daniel Clauw
Member of Scientific Advisory Board3yrsno datano data
Robin Carhart-Harris
Chairman of Scientific Advisory Board3.4yrsno datano data
Rachel Wevrick
Member of Scientific Advisory Boardno datano datano data
Derek Ott
Member of Scientific Advisory Boardno datano datano data
Joel Castellanos
Member of Scientific Advisory Board3.4yrsno datano data
Clarke Barlow
Independent Non-Executive Directorno datano data0.035%
CA$ 11.2k

3.4yrs

Average Tenure

52yo

Average Age

Experienced Board: TYP's board of directors are considered experienced (3.4 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.